CB
Corvese Brian
Director
BoardM
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Corvese Brian, Director. Insider active across 2 companies, notably AGENUS INC. Aggregated, 17 filings have been published. History available since 15 September 2022. The latest transaction was disclosed on 1 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Corvese Brian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
1,640 shares@ US$10.906.5% of flowCommon StockSEC:0001193125-26-253468:0
1,444 shares@ US$12.380.029% mcap6.6% of flowCommon StockSEC:0001193125-26-253468:1
1,612 shares@ US$11.095.5% of flowCommon StockSEC:0001193125-25-306681:0
1,290 shares@ US$13.865.8% of flowCommon StockSEC:0000950170-25-112884:0
2,494 shares@ US$7.176.3% of flowCommon StockSEC:0000950170-25-081610:0
2,033 shares@ US$8.797.4% of flowCommon StockSEC:0000950170-25-033522:0
24,400 shares@ US$0.737.2% of flowCommon StockSEC:0000950170-24-132524:0
21,802 shares@ US$0.826.9% of flowCommon StockSEC:0000950170-24-103740:0
17,967 shares@ US$0.997.0% of flowCommon StockSEC:0000950170-24-069211:0
18,816 shares@ US$0.957.1% of flowCommon StockSEC:0000950170-24-026421:0
17,188 shares@ US$1.047.0% of flowCommon StockSEC:0000950170-23-068313:0
12,244 shares@ US$1.467.1% of flowCommon StockSEC:0000950170-23-046776:0
10,157 shares@ US$1.767.1% of flowCommon StockSEC:0000899243-23-014415:0
8,553 shares@ US$2.097.3% of flowCommon StockSEC:0000899243-23-006922:0
6,849 shares@ US$2.617.4% of flowCommon StockSEC:0000899243-22-037653:0
13,646 shares@ US$2.6215.4% of flowCommon StockSEC:0000899243-22-031523:0
22,471 sharesCommon StockSEC:0000899243-21-025084:0
About Corvese Brian
Corvese Brian is Administrateur of MiNK Therapeutics, Inc. and AGENUS INC. The record shows 17 filings, all in the sample held, covering the period from 2021-06-21 to 2026-06-02, with the dominant transaction nature listed as Attribution, and buy and sell amounts of 0; the largest sampled filings are for MiNK Therapeutics, Inc. at 35794.35172310799 on 2022-09-19, 17159.91223239445 on 2025-03-05, 17146.55404938424 on 2022-12-05, 16900.11115072542 on 2023-03-03, 16862.61969683872 on 2024-12-03, and 16612.46412074795 on 2023-06-02.